Friday, November 6, 2020
1:00PM – 2:00 PM ET
This virtual program is at 1:00PM Eastern, 12:00PM Central, 11:00AM Mountain, and 10:00AM Pacific.
PROGRAM OVERVIEW
- Online Personalized Poster Portal
- Interactive, case-based learning environment
FACULTY
Russell P. Rosenberg, PhD
Chief Science Officer and CEO
NeuroTrials Research, Inc
Founder and Director
Atlanta School of Sleep Medicine and Technology.
Atlanta, GA
TARGET AUDIENCE
This initiative is designed to meet the educational needs of U.S.-based neurologists, internists,
pulmonologists, psychiatrists, and sleep specialists who treat patients who have or are at risk for sleep-related disorders.
LEARNING OBJECTIVES
On completing the program, attendees should be able to:
- Discuss the recognition of impaired daytime wakefulness and Excessive Daytime Sleepiness (EDS) due to either narcolepsy or OSA
- Describe patients at risk for EDS and impaired wakefulness, resulting in prompt referral and diagnosis
- Review the uses and limitations of currently available pharmacologic options for people with EDS due to either OSA or narcolepsy
- Evaluate clinical trial data for agents to treat impaired wakefulness and EDS in patients with either OSA or narcolepsy
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in treating and managing patients with sleep-related disorders.
Credits:
1.0 ANCC Contact Hours
CNE ACCREDITATION STATEMENT:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hours of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected].
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
